SCHEMBL24866846

SCHEMBL24866846

CCc1cccc2c1C(F)(F)C(=O)N2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.41
TP53 P04637 1/20 0.39
MAPT P10636 4/20 0.37
LMNA P02545 4/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
DRD3 P35462 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16255575 0.81 MAPT (0.49) MGLLTP53MAPTLMNAKMT2A
SCHEMBL19704112 0.77 MGLL (0.39) MGLLMAPTLMNAKMT2AMEN1
SCHEMBL30082327 0.77 MGLL (0.39) MGLLMAPTLMNAKMT2AMEN1
SCHEMBL21726268 0.75 FAAH (0.41) MGLLMAPTLMNAKMT2AMEN1
SCHEMBL30667005 0.73 OPRM1 (0.43) MGLLTP53MAPTLMNAKMT2A
SCHEMBL22984927 0.71 MGLL (0.34) MGLLTP53MAPTLMNAKMT2A
SCHEMBL15599566 0.71 MAPT (0.54) MAPTLMNAKDM4EALDH1A1HPGD
SCHEMBL30194888 0.71 MAPT (0.54) MAPTLMNAKDM4EALDH1A1HPGD
SCHEMBL30667308 0.69 OPRM1 (0.40) MGLLMAPTLMNAKMT2AMEN1
SCHEMBL26922415 0.69 JAK2 (0.44) MAPTLMNAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230010886-A1 SHP2 INHIBITORS AND USES THEREOF Suzhou Puhe BioPharma Co., Ltd. (CN) 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230010886-A1 SHP2 INHIBITORS AND USES THEREOF PTPN1, PTPN7, PTPN18 MGLL 3451/4885TP53 169/4885MAPT 4707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.